Cited by 352Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer’s Disease and Related Therapeutic Targets

Open access

Cai, Yongle, Liu, Jingliu, Wang, Bin, Sun, Miao, Yang, Hao·2022·Frontiers in Immunology

DOI 10.3389/fimmu.2022.856376PMC PMC9086828

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease worldwide, characterized by progressive neuron degeneration or loss due to excessive accumulation of β-amyloid (Aβ) peptides, formation of neurofibrillary tangles (NFTs), and hyperphosphorylated tau. The treatment of AD has been only partially successful as the majority of the pharmacotherapies on the market may alleviate some of the symptoms. In the occurrence of AD, increasing attention has been paid to neurodegeneration, while the resident glial cells, like microglia are also observed. Microglia, a kind of crucial glial cells associated with the innate immune response, functions as double-edge sword role in CNS. They exert a beneficial or detrimental influence on the adjacent neurons through secretion of both pro-inflammatory cytokines as well as neurotrophic factors. In addition, their endocytosis of debris and toxic protein like Aβ and tau ensures homeostasis of the neuronal microenvironment. In this review, we will systematically summarize recent research regarding the roles of microglia in AD pathology and latest microglia-associated therapeutic targets mainly including pro-inflammatory genes, anti-inflammatory genes and phagocytosis at length, some of which are contradictory and controversial and warrant to further be investigated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3389/fimmu.2022.856376

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 The role of microglia in AD progression. The clearance of Aβ mediated by microglia contributes to the homeostasis maintenance of CNS. But, with the AD progression, excessive activation of microglia would release excessive pro-inflammatory factors to compromise neurons and their synapses.CC BY · PubMed Central

Figure 2 NLRP3 inflammasome and IDE in microglia of AD. The NLRP3 inflammasome accelerates microglial inflammation and can be inhibited by various substances. The secretion of IDE helps degrade Aβ and is regulated by diverse drugs.CC BY · PubMed Central

Figure 3 NF-κB pathway in microglia of AD. NF-κB signal pathway plays a central role in microglia-mediated neuroinflammation. This figure introduces multiple drugs mentioned in this review above, and their effects on microglia at length via NF-κB signal pathway.CC BY · PubMed Central

Figure 4 Microglial phagocytosis and autophagy in AD. Microglia eliminate Aβ load through phagocytosis and autophagy. This figure displays the regulatory mechanism of this process.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,184
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
The Inflammasome
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244

Show all 169 references

Sorted by citations

Items 201–300 of 352

Anti-inflammatory activity of Kyungok-go on Lipopolysaccharide-Stimulated BV-2 Microglia Cells
Song, H.-S., An, J.-Y., Oh, J.-Y., Kim, D.-U., Kweon, B., Park, S., & Bae, G. (2022) · 대한한의학회지 · doi:10.13048/jkm.22044 · Cited by 4
Differential Expression of GABA Receptor-Related Genes in Alzheimer’s Disease and the Positive Regulatory Role of Aerobic Exercise-From Genetic Screening to D-gal-induced AD-like Pathology Model
Liu, Y., Peng, H., Liu, Q., Hao, J., Tang, C., & Yan, H. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08821-1 · Cited by 3
Biochanin-A: A Potential Candidate for the Treatment of Alzheimer’s Disease
Singh, N. K., & Bhushan, B. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010362795250223160707 · Cited by 3
The Fate and Dynamics of Neural Stem Cells (NSCs) and Their Neurogenic Decline in Alzheimer’s Disease
Naffaa, M. M. (2025) · Lifespan development and mental health. · doi:10.70322/ldmh.2025.10005 · Cited by 3
Trends and Hotspots in Research on Exercise and Alzheimer’s Disease: A Decade of Bibliometric Review on Prevention and Molecular Mechanisms
Yang, X., Li, K., Zhang, Y., Sun, R., & Yu, J. (2025) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2025.241016 · Cited by 3
Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease
Wang, H., Yang, Q., Ge, C., Liu, J., Mistry, H., Jia, Y., & He, G. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251361042 · Cited by 4
Self-citation
Jiao-Tai-Wan Improves Cognitive Impairment by Regulating Nrf2/ARE/HO-1 Signaling Pathway in APP/PS1 Mice
Wang, X.-C., Wu, G., Cai, H., Chu, C.-L., Liu, Y., Li, H.-C., Zheng, J. G., Chen, H., Lin, H., Li, S., et al. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04515-7 · Cited by 3
Therapeutic implications of allopregnanolone in Alzheimer’s related depression
Tidke, B., Itekar, S., Khobragade, R., Vinchurney, M. D., Trivedi, R., Taksande, B. G., & Umekar, M. J. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115785 · Cited by 3
Exploring Thiophene-Based Pharmacophores as Emerging Therapeutics for Neurodegenerative Disorders
Sharma, S., Gupta, M., & Sharma, S. (2025) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2025.2554239 · Cited by 4
Potential connections between senescence and chemobrain: An early overview of literature
Melhem, N. Y., Qutifan, S., Alsalem, M., & Saleh, T. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102896 · Cited by 4
RRBP1 Inhibition Reduces Microglial M1 Polarization and Inflammation-Mediated Neuronal Loss and Oxidative Stress by Regulating ERK Pathway in Alzheimer’s Disease
Li, Y., Fan, H., Han, X., Ni, M., Hou, X., Xia, H., Shi, Y., Zhang, L., & Sun, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05287-5 · Cited by 3
β-Alanine Is an Unexploited Neurotransmitter in the Pathogenesis and Treatment of Alzheimer’s Disease
Wozniczka, C. M., & Weaver, D. F. (2026) · NeuroSci · doi:10.3390/neurosci7010013 · Cited by 3
β‐Asarone Attenuates Neuroinflammation of Alzheimer's Disease by Activating Autophagy and Suppressing NLRP3 Inflammasome Assembly
Xu, Z., Xu, W., He, J., Qian, J., Wang, H., Li, C., & Zhou, X. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70771 · Cited by 3
β-Asarone Mediates the Alleviation of Neuroinflammation in Alzheimer’s Disease Via Modulation of the TREM2/PI3K/AKT Signaling Pathway
Yang, N., Jiang, J., Shi, J., Liu, X., Yu, C., Guo, S., Zhang, C., Gao, F., Yang, Z., Feng, H., et al. (2026) · Inflammation · doi:10.1007/s10753-025-02435-w · Cited by 4
Progress of p53 Involvement in Central Nervous System Diseases and Targeted Drug Discovery
Xu, F., Liu, Z., Wang, Z., Zhang, Y., Zhao, Y., & Fang, W. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70089 · Cited by 3
The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer’s disease
Sun, X., Liu, H., Li, W., Li, L., Tian, Q., Cao, Q., Meng, Y., Shen, Y., Che, F., Chiu, J. C., et al. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00449-7 · Cited by 3
Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis
Zhai, Z., Kong, F., Zhu, Z., Dai, J., Cai, J., Xie, D., Shen, Y., Xu, Y., & Sun, T. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.11.011 · Cited by 4
A New Cell Model Overexpressing sTGFBR3 for Studying Alzheimer's Disease In vitro
Chen, J., Zhou, L., Zhao, Q., & Qi, Z. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128278324240115104615 · Cited by 3
PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
Kumar, M., Sharma, A. A., Datusalia, A. K., & Khatik, G. L. (2024) · Medicinal Chemistry · doi:10.2174/0115734064295063240422100615 · Cited by 3
Multi-Target Drug Strategies in the Treatment of Diabetic Retinopathy
Julius, A., Malakondaiah, S., Subbarayalu, R., Renuka, R. R., & Pothireddy, R. B. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01936-x · Cited by 3
Amyloid-β-regulated gene circuits for programmable Alzheimer’s disease therapyPreprint
Spetz, M. R., Kim, H., Ligocki, A. P., Shekharan, S. R., Brien, H. J., Chavarría, D., Conger, D. J., Shattuck-Brandt, R. L., Shostak, A., Embalabala, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.12.642808 · Cited by 3
Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative riskPreprint
Perez‐Alcantara, M., Washer, S. J., Chen, Y., Steer, J., González‐Padilla, D., McWilliam, J., Willé, D. R., Panousis, N., Kolberg, P., Navarro‐Guerrero, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.18.670767 · Cited by 3
Methods of physical exercise for older adults with Alzheimer's and the factors that hinder its practice: a systematic review
de Andrade, Á. D. B., Ide, F. C., Mangia, A. S., Martins, A. C., Nascimento, A. Q., & do Nascimento, I. B. (2024) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562024027.240007.en · Cited by 2
Heat shock protein and Alzheimer’s disease: an updated systematic review
Raza, H., Ali, A., Kumar, A., Adnan, F., Shah, S. A. W., Ghazanfar, S., Roshan, F. N. U., Shamim, Z., Opare, A. D., & Tanveer, F. S. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002887 · Cited by 2
Exploring the Link Between Allergies and Neurological Diseases: Unveiling the Hidden Connections
Saramak, K. (2025) · Allergies · doi:10.3390/allergies5020018 · Cited by 2
Effectiveness of acupuncture combined with donepezil for Alzheimer’s disease: A systematic review and meta-analysis
Wu, Y., Zhan, Y., Zhu, W., & Pei, J. (2025) · Medicine · doi:10.1097/md.0000000000042651 · Cited by 2
Scorpion venom heat‐resistant synthetic peptide improves cognitive dysfunction of APP/PS1 mice through microglial retromer complex
Zhang, Y., Wu, Y., Zhang, X., Guo, S., He, J., Hu, N., Huang, Y., Kong, Y., Li, Q., Sui, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70124 · Cited by 2
Neuroprotective mechanism of LincRNA in neurodegenerative diseases
Lin, Y., Wang, J., Liu, B., Hu, T., & Gu, J. (2025) · Gene · doi:10.1016/j.gene.2025.149722 · Cited by 2
Exosomes as Emerging Therapeutic Platforms in Neurological and Psychiatric Disorders
Kumar, R. M. R., Logesh, R., & Chidambaram, S. B. (2025) · Pharmaceutical Medicine · doi:10.1007/s40290-025-00584-9 · Cited by 4
Bacterial infection hypothesis-based therapies for Alzheimer's disease
Teng, M., Ma, R., Liu, S., Zhang, G., Zou, J., & Fu, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169535 · Cited by 3
Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)
Chauhan, A., Devi, R., Singh, S., Bhutani, K., Prasad, S., Singh, A., Bhaskar, N., Kumar, S., Saini, A. K., & Thakur, R. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00217-6 · Cited by 5
Therapeutic efficacy of rehmannioside A on 5×FAD mice in Alzheimer’s disease
Lai, Y., & Zhao, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-23434-9 · Cited by 2
Targeting Neuroinflammation in Synaptic Dysfunction: Translational Pharmacology for Neurodegenerative and Neuropsychiatric Disorders
Bhatia, N., Khan, M. M. U., Masih, D., & Srinivas, U. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00318-w · Cited by 2
Utilisation of Machine Learning Approaches Improves RNA-Seq Transcriptome Analyses in Alzheimer’s Disease Brain
Cheng, Y., Santucci, K., Gao, Y., Takenaka, K., Lindner, G., Xu, S.-M., & Janitz, M. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02469-7 · Cited by 3
Fucoxanthin Extracted from the Microalgae Phaeodactylum tricornutum Ameliorates Alzheimer’s Pathologies with the Reduction of Aβ-Induced NLRP3 Inflammasome Activation in APP/PS1 Mice
Ahn, N.-H., Hong, S.-C., Hong, C. R., Lee, E. H., Lee, J. H., Choi, S.-B., Jung, J., Kim, Y., Kim, J.-S., Park, K., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05680-8 · Cited by 2
Peptide-Based Therapeutics for Alzheimer’s Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood–Brain Barrier Delivery
Khzem, A. H. A., & Gomaa, M. S. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s597087 · Cited by 3
Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer’s Disease: A Recent Review
Kumar, D., Kondaveeti, S. B., Agrawal, M., Kumar, A., Awasthi, A., Mahmood, S., Singh, T. G., & Kumar, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05857-1 · Cited by 2
Using iPSC models to examine neuron–glia interactions in neurodegenerative diseases
Lopez, D. M., Keavey, L., & Bowles, K. R. (2026) · Bioscience Reports · doi:10.1042/bsr20250131 · Cited by 2
Vitamin D in Alzheimer's disease: Neuroinflammatory, metabolic, and clinical implications
Kashif, M., Ho, M.-H., Pandurangan, A. K., Waseem, M., Majumder, D., & Chou, S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460850 · Cited by 4
Double-strand-break repair protein rad21 homolog/Synaptotagmin-7 alleviates Alzheimer's disease in mice by promoting M2 polarization of microglia
Zhu, C., Xu, J., Lin, J., Liu, J., & Yu, E. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110994 · Cited by 2
Self-citation
Egln3 expression in microglia enhances the neuroinflammatory responses in Alzheimer’s disease
Guan, J., Wu, P., Liu, M., Jiang, C., Meng, X., Wu, X., Lu, M., Fan, Y., & Gan, L. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.022 · Cited by 3
Predicting Suicidal Ideation and Attempts Using Biomarkers: Hope for Death Prevention in a Depressed Society
Emokpae, M. A., Osifo, J. O., Emokpae, L. A., ERHUNMWUNSE, R. U., & Ayomide, I. B. (2024) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2024.1412020 · Cited by 2
Association of CSF soluble TREM1 levels with hippocampal atrophy in cognitively impaired older adults
Shu, H., Ding, G., Xu, X., Huang, X., & He, R. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1481526 · Cited by 2
Complementary Strategies to Identify Differentially Expressed Genes in the Choroid Plexus of Patients with Progressive Multiple Sclerosis
Rodrigues, A. B. M., Passetti, F., & Guimarães, A. C. R. (2025) · Neuroinformatics · doi:10.1007/s12021-024-09713-2 · Cited by 2
PPM1D ameliorates Alzheimer's disease by promoting mitophagy
Wang, A., Zhang, F., Zhang, W., Gong, J., & Sun, X. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115218 · Cited by 2
Effects of Bufexamac, a class IIb HDAC inhibitor, on behavior and neuropathological features in an Aβ-induced rat model of Alzheimer's disease
Mirehei, M., Motamedi, F., Maghsoudi, N., Mansouri, Z., Naderi, S., Khodagholi, F., & Abbaszadeh, F. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112746 · Cited by 2
GABA-enriched probiotic nanoformulation: A novel nutritional intervention against acrylamide neurotoxicity and inflammation
Babaker, M. A., Ghany, K. A. E., Elshafey, N., Algohary, A. M., Elgohary, E., Hamouda, R. A., Abol-Fetouh, G. M., Elbawab, R. H., & Ahmed-Farid, O. A.-H. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107194 · Cited by 2
Non-Steroidal Anti-Inflammatory Drugs as Protective Factor in Alzheimer’s Diseases: A Systematic Review and Meta-Analysis Protocol
Asthana, A., Agarwal, R., & Tripathi, S. (2023) · Advances in Alzheimer s Disease · doi:10.4236/aad.2023.122002 · Cited by 2
Cannabidiol reverses fentanyl-induced addiction and modulates neuroinflammationPreprint
Bhandari, B., Chagas, H. I. S., Naeini, S. E., Chagas, P. S., Rogers, H. M., Gouron, J., Khan, A., Maciel, L. M., Seyyedi, M., MacKinnon, N. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.20.604441 · Cited by 2
Progress of Chinese Medicine in Regulating Microglial Polarization against Alzheimer’s Disease
Yang, F., Gao, W., Wang, J. Z., Li, X., & Li, H. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500873 · Cited by 1
Photobiomodulation Ameliorates Neuronal Damage in an Amyloid-Beta Induced Rat Model
Li, N., Liu, N., Ye, Y., Shi, H., Shi, J., Luo, G., Guo, J., Liu, Y., & Chen, H. (2025) · IEEE Journal of Selected Topics in Quantum Electronics · doi:10.1109/jstqe.2025.3564366 · Cited by 1
Anemia in Neurodegenerative Disorders: Implications for Cognitive Decline and Disease Progression
Omutindo Nyakayo, A. (2025) · NEWPORT INTERNATIONAL JOURNAL OF RESEARCH IN MEDICAL SCIENCES · doi:10.59298/nijrms/2025/6.2.4752 · Cited by 1
Flavanol-hydroxytyrosol hybrids and diterpenoids with anti-neuroinflammatory activity by regulating the expressions of NF-κB and IL-1β in vitro from Tripterygium hypoglaucum rhizomes
Lin, Z., Qiao, W., Wang, J., Tang, Z., Shi, L., Qian, Q., Hu, W., Zhang, R., & Chen, X. (2025) · Phytochemistry · doi:10.1016/j.phytochem.2025.114566 · Cited by 1
The inhibitory effects and mechanisms of milk-derived MFG-E8 on Aβ-induced inflammatory responses in BV-2 microglia
Li, D., Mu, X., Ma, Y., Lu, W., & Wang, R. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250621 · Cited by 1
Computational and Experimental Validation of Anti-LPS-Induced Alzheimer’s Disease Effects of Pterocarpus mildbraedii and its Compounds: Combining Network Pharmacology, Molecular Docking, In Vitro , and In Vivo Approaches
Sandrine, M. N. Y., Owona, P. E., Ella, F. A., Bilanda, D. C., Julie, A. O. J., Cynthia, B. Y. P., Michel, B. G., Dzeufiet, P. D. D., Binsaleh, A. Y., Alwethaynani, M. S., et al. (2025) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416525501248 · Cited by 1
A systemic and dialectical paradigm for Psychoneuroendocrineimmunology and integrated care science
Bottaccioli, F., & Bottaccioli, A. G. (2025) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2025.100138 · Cited by 1
Galectin-3 in Alzheimer’s disease: pathological roles, biomarker potential, and therapeutic implications
Akash, A., Ahamed, M., Porel, P., & Aran, K. R. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149949 · Cited by 2
Protective effect of adult vaccination on the development of dementias: A systematic review
Mariscal-López, E., Agredano-Sanchez, M., Lopez-Gigosos, R. M., Mariscal, A., Fariñas-Guerrero, F., Gutiérrez‐Bedmar, M., & Guts-Chornoknyzha, M. (2025) · Neurología · doi:10.1016/j.nrl.2025.501939 · Cited by 1
Asparagine Deamidation Attenuates Toxicity, Aggregation, and Microglial Responses of Alzheimer’s Amyloid-β
Sajimon, M., Wheeler, C. J., Foley, A. R., Chan, K., Griffin, M. N., Dinakarapandian, D. M., Holberton, A. L., Joy, J., Paravastu, A. K., Wood, L. B., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00544 · Cited by 2
TLRs and NLRs modulate oral microbiome involvement in Alzheimer’s disease
Motevalli, H., Mehrani, A., Zolfaghari, K., Khodaee, P., Yazdanpanah, N., Saleki, K., & Rezaei, N. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01771-y · Cited by 1
Protective Effects of Arecoline on LPS-Induced Neuroinflammation in BV2 Microglial Cells
Zhang, X., Cui, J., Sun, J., Fan, B., Wang, F., & Lu, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412097 · Cited by 1
Cell-based immunotherapy for neurodegenerative disease: A promising avenue
Huerta, T. J., Urbina-Muñoz, V., Urra-Alvarez, V., Villablanca, C., Gómez‐Pérez, L. S., Saavedra, B., Contreras, T., & Vidal, R. L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00816 · Cited by 1
Neuroprotective Effects of Lutein: Considering Microglial Activation and Oxidative Stress
Jain, A., Srivastava, S., Kumar, S., Sahu, R., Tariq, M., & Ashraf, G. M. (2026) · Springer eBooks · doi:10.1007/978-981-95-4751-7_5 · Cited by 1
A metabolic perspective on microglia in Alzheimer’s disease
Sangineto, M., & Serviddio, G. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01035 · Cited by 1
Circadian Disruption Through Light–Dark Cycle Alteration Induced Alzheimer’s Disease-like Pathology in Mice
Zhao, G., Cui, B., Lu, Y., Ma, K., Gao, X., She, X., Zhu, Y., Ji, X., Yang, H. M., & Yang, H. (2026) · Biomolecules · doi:10.3390/biom16020200 · Cited by 1
Self-citation
Zinc‐Based Nanocomposites for Alzheimer's Therapy: Restoring Metal Homeostasis and Inhibiting Neurotoxic Protein Aggregation
Yadav, S., Pandey, S. K., & Awasthi, S. (2026) · Advanced Therapeutics · doi:10.1002/adtp.202500576 · Cited by 1
Altered Microglia-Neuron Crosstalk and Regional Heterogeneity in Alzheimer’s Disease Revealed by Single-Nucleus RNA Sequencing
Yang, Z., Zhang, M., Zhi, W., Lizhen, Hu, X., Zou, Y., & Wang, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031492 · Cited by 3
A systemic and dialectical paradigm for Psychoneuroendocrineimmunology and integrated care science
Bottaccioli, F., & Bottaccioli, A. G. (2026) · PNEI REVIEW · doi:10.3280/pnei2025oa21668 · Cited by 1
Lysine demethylase 1A alleviates Alzheimer disease progression by regulating the leucine carboxyl methyltransferase 1/protein phosphatase 2 catalytic subunit alpha/transcription factor EB pathway via O‐GlcNAcase‐mediated forkhead box transcription factor A2 O‐GlcNAcylation modification
Cao, J., Song, J., Yin, Z., & Tang, Z. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70289 · Cited by 1
Morpho-Functional Characterization and miRNA Profiling of the Retina in the 5xFAD Murine Model of Alzheimer's Disease
Guidotti, L., Lucchesi, M., Daghini, E., Amato, R., Neri, G., Corsi, F., Marracci, S., Gargini, C., Borello, U., Cammalleri, M., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.2.31 · Cited by 1
Combined with network pharmacology, the therapeutic effect and mechanism of coumarins from Chimonanthus praecox extract in the treatment of Alzheimer’s disease were investigated
Zhu, S., Li, Y., Lin, C., Liu, X., Luo, Y., Qian, H., & Tang, Z. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05225-9 · Cited by 1
Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease
Ye, Q., & Ma, S. (2026) · Molecules · doi:10.3390/molecules31081272 · Cited by 2
DHCR24 in cholesterol metabolism and diseases of the nervous system
Zhu, H. G., Li, S., Yang, Y. Z., 张似青, Wang, Y., & Xiong, T. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02954-x · Cited by 2
Bacillus Calmette–Guérin (BCG) Vaccination and the Immune–Brain Axis: Implications for Neuroprotection and Neurodegenerative Disease
Druszczyńska, M., Sadowska, B., Kulesza, J., Kulesza, E., & Fol, M. (2026) · Vaccines · doi:10.3390/vaccines14050412 · Cited by 2
Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges
Setiawan, A. W., Choi, J. T., Park, S., Choi, M., Tjandrawinata, R. R., Hadinata, E., Park, M. N., Ikrar, T., Nurkolis, F., & Kim, B. (2026) · Pharmaceuticals · doi:10.3390/ph19050792 · Cited by 1
Intranasal Adipose-Derived MSC Extracellular Vesicles Confer Sustained Cognitive Improvement and Suppress Alzheimer’s Pathology in APP/PS1 Mice
Tian, M., Feng, R., Gong, C., Ben, X., Ma, Z., Yi, X., & Guo, Q. (2026) · Biomolecules · doi:10.3390/biom16060798 · Cited by 1
Nutrients and bioactive compounds as modifiers of neurodegenerative trajectories: molecular mechanisms, translational barriers, and precision nutrition
Singh, G., Singh, G., Shreya, Kumari, A., & Aran, K. R. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1819432 · Cited by 1
Reprogramming Neuroinflammation: Mitochondrial Targets and Immune Checkpoint Inhibitors in Alzheimer’s Disease
Kumar, N., Mir, P. A., Bhutia, G. T., Chaudhary, P., Kaur, G., Alam, Q., Pawar, S. D., & Gupta, S. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05983-w · Cited by 1
Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease
Hill, N., AlMuallim, H. Y. O., Maddock, E., Hobbs, C., Clarke, E. E., Goncalves, M. B. C. V., & Corcoran, J. P. T. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70284 · Cited by 1
Innovative Test Strip‐Based Colorimetric Sensors Integrated With Affinity Chromatography: Acetylcholinesterase Inhibitor Screening Breakthrough in Lycium Barbarum Leaves
Sa, Y., Yuan, H., Ma, J., Yang, Z., Wang, M., Wang, W., Yang, L., Ma, F., Zhang, W., Wilson, G., et al. (2026) · Advanced Science · doi:10.1002/advs.76863 · Cited by 1
Scientific Evidence of Baduanjin Improving Cognitive Function in Patients with Cognitive Impairment
唐, 琼. (2024) · Open Journal of Natural Science · doi:10.12677/ojns.2024.122032 · Cited by 1
Molecular Docking, Synthesis, and Characterization of Furanyl‐Pyrazolyl Acetamide and 2,4‐Thiazolidinyl‐Furan‐3‐Carboxamide Derivatives as Neuroinflammatory Protective Agents
Mudimela, S., Giridharan, V. V., & Saravanan, J. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301260 · Cited by 1
Parkinson’s Disease Progression and Treatment Dynamics Accounting for Nonlocality of Bioneurological Processes
Pal, S., & Melnik, R. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-64636-2_4 · Cited by 1
Phikud navakot extract acts as an ER stress inhibitor to ameliorate ER stress and neuroinflammation
Temviriyanukul, P., Chansawhang, A., Inthachat, W., Supasawat, P., Phochantachinda, S., Pitchakarn, P., & Chantong, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39700 · Cited by 1
Deciphering motor dysfunction and microglial activation in mThy1-α-synuclein mice: a comprehensive study of behavioral, gene expression, and methylation changes
McGregor, B. A., Raihan, M. O., Brishti, A., Hur, J., & Porter, J. E. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1544971 · Cited by 1
Metabolic Reprogramming in Primary Microglial Cell and Extracellular Vesicle Triggered by Aβ Exposure
Bong, S., Choi, H., Song, H., Kim, D. K., Mook‐Jung, I., & Lee, D. Y. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70030 · Cited by 1
Increased seizure susceptibility in the collagen-induced arthritis mouse model depends on neuronal IL-1R1
Chen, S., Chen, R., Luo, M., Luo, Y., Ma, X., Zhao, H., & Xu, Z. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123537 · Cited by 1
Cystamine reduces neurodegeneration and epileptogenesis following soman-induced status epilepticus in rats
Biney, A. K., Schultz, C. R., Stone, M. F., Nguyen, D. A., Wang, A., Furtado, M. D. A., & Lumley, L. A. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10598 · Cited by 1
Intranasal administration of stem cell therapy: A promising approach for early Alzheimer’s disease intervention
Fatima, E., & Fatima, A. (2025) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2025.07.002 · Cited by 1
The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila and cellular models of Alzheimer's diseasePreprint
Sun, X., Li, W., Li, L., Tian, Q., Cao, Q., Fu, Q., Meng, Y., Shen, Y., Yu, J., & Che, F. (2023) · Research Square · doi:10.21203/rs.3.rs-3481982/v1 · Cited by 1
Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease
Miao, J., Wang, J., Li, Y., Zhang, H., Zhang, Y., Li, Q., Xiao, B., Zhou, W., & Guo, J. (2026) · Advanced Science · doi:10.1002/advs.77929
“This contributes to CAA, BBB breakdown, and microglial overactivation [ 15, 21–23 ].”
Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis?
Chmiel, J., Gawełczyk, W., Soczyńska, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15131151
CUIDADOS PALIATIVOS NA DOENÇA DE ALZHEIMER: RELATO DE EXPERIÊNCIA
Moura, C. A. D., & Lopes, G. D. S. (2023) · Revista Contemporânea · doi:10.56083/rcv3n12-151
Role of Exosomes in Management of Depression
Nigade, A., Pathak, G., Anitha, K., Mishra, N., Bali, V., & Bhatt, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8373-5_8
Osteocalcin Alters Aggregation Pattern of Abeta42 to Form Complexes (Ao) that Aid in Amyloid Reduction in Mouse Models of Alzheimer DiseasePreprint
Vijayan, V., Siddique, I. A., Gupta, S., Madan, E., Raj, N., & gupta, S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4863165
Métodos de exercícios físicos para pessoas idosas com Alzheimer e os fatores que dificultam a sua prática: uma revisão sistemática
de Andrade, Á. D. B., Ide, F. C., Mangia, A. S., Martins, A. C., Nascimento, A. Q., & do Nascimento, I. B. (2024) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562024027.240007.pt
Interação dos receptores P2X7 e TRPV1 na ativação do inflamassoma NLRP3 e na liberação de vesículas extracelulares na linhagem murina de micróglia BV2
Bastos, S. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-25072024-110328
Alzheimer's disease: therapeutic potential of phytocannabinoids
da Silva, T. C. C., da Silva, A. R., Campagnone, C. H. D. S., Alves, A. J., & da Silva, V. A. (2024) · Concilium · doi:10.53660/clm-3910-24q30
Growing microglia in the lab
Levenson, J. M., Kam, H., & Chen, D. F. (2024) · eLife · doi:10.7554/elife.103535
Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies
Murshid, N. M., Sahardi, N. F. N. M., & Makpol, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010241

Authors: Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H.
Affiliations: First Affiliated Hospital of Soochow University (CN)
Corresponding author: Sun, Miao
Yang, Hao
ORCID: Wang, Bin
Sun, Miao
Yang, Hao
Venue: Frontiers in Immunology
Publisher: Frontiers Media SA
Published: 2022-04-26
Volume: 13
Pages: 856376-856376
ISSN: 1664-3224 (ISSN-L)
DOI: 10.3389/fimmu.2022.856376
PMC: PMC9086828
OpenAlex: W4281554374
Cited by: 351
References: 169
Citations by year: 2026: 70 · 2025: 148 · 2024: 88 · 2023: 41 · 2022: 4
FWCI: 7.24
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Frontiers in Immunology (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: National Natural Science Foundation of China (81,570,960, 81,974,244, 82071551, 2019YFA0802600)
Government of Jiangsu Province
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: microglia, Alzheimer's disease, neuroinflammation, neurodegeneration, amyloid-beta, tau hyperphosphorylation, neurofibrillary tangles, inflammatory cytokines, anti-inflammatory genes, phagocytosis, microglial homeostasis, therapeutic target
MeSH terms: Alzheimer Disease, Humans, Neurons, Amyloid beta-Peptides, Microglia, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer’s Disease and Related Therapeutic Targets

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks